• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖尿病肾病患者转为透析后严重低血糖及随后死亡率的时间趋势

Temporal Trends of Severe Hypoglycemia and Subsequent Mortality in Patients with Advanced Diabetic Kidney Diseases Transitioning to Dialysis.

作者信息

Hsiao Ching-Chung, Tu Hui-Tzu, Lin Chi-Hung, Chen Kuan-Hsing, Yeh Yung-Hsin, See Lai-Chu

机构信息

Kidney Research Center and Department of Nephrology, Chang Gung Memorial Hospital, Taipei 333, Taiwan.

Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan 333, Taiwan.

出版信息

J Clin Med. 2019 Mar 27;8(4):420. doi: 10.3390/jcm8040420.

DOI:10.3390/jcm8040420
PMID:30934740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6518047/
Abstract

BACKGROUND

Patients with diabetic kidney disease (DKD) are at higher risk of hypoglycemia than diabetic patients without DKD. We aimed to investigate the temporal trends of severe hypoglycemia in advanced DKD patients transitioning to dialysis and examine risk factors associated with severe hypoglycemia. We also investigated the association of severe hypoglycemia episodes with one-year mortality after initiation of dialysis in patients with advanced DKD.

METHODS

Using the Taiwan National Health Insurance Research Database, 46,779 advanced DKD patients transitioning to dialysis (Peritoneal dialysis 4216, hemodialysis 42,563) between 1997 and 2011 were enrolled. We calculated the rates of severe hypoglycemia from 5 years before dialysis until 10 years after dialysis. Cox proportional hazard model was used to examine the risk factors of post end stage renal disease (ESRD) one-year hypoglycemia and post ESRD one-year mortality in advanced DKD patients transitioning to dialysis.

RESULTS

We found that 11.5% of advanced DKD patients had at least one episode of severe hypoglycemia the year leading up to dialysis initiation. Multivariate analysis revealed hemodialysis compared with peritoneal dialysis, stroke, use of sulfonylurea, glinide, and insulin were associated with higher risk of severe hypoglycemia one year after transitioning to dialysis. Increased frequency of severe hypoglycemia-related hospitalizations was associated with incrementally higher mortality risk one year after transitioning to dialysis (Pre-ESRD hypoglycemia: Hazard ratios: 1.28 (1.18⁻1.38, < 0.001), 1.64 (1.49⁻1.81, < 0.001) for one, two hypoglycemia-related hospitalizations, respectively; post-ESRD hypoglycemia: HRs of 1.56 (1.40⁻1.73, < 0.001), 1.72 (1.39⁻2.12, < 0.001) for one, two hypoglycemia-related hospitalizations, respectively (reference group: no hypoglycemia related hospitalization)).

CONCLUSIONS

Among advanced DKD patients, we observed a progressive elevated risk of hypoglycemia during the critical dialysis transition period. Increased frequency of severe hypoglycemia-related hospitalizations was associated with higher mortality risk one year after transitioning to dialysis. Further study of glycemic management strategies which prevent hypoglycemia during the critical transition period are warranted.

摘要

背景

与无糖尿病肾病(DKD)的糖尿病患者相比,DKD患者发生低血糖的风险更高。我们旨在调查晚期DKD患者转为透析时严重低血糖的时间趋势,并研究与严重低血糖相关的危险因素。我们还研究了晚期DKD患者开始透析后严重低血糖发作与一年死亡率之间的关联。

方法

利用台湾国民健康保险研究数据库,纳入了1997年至2011年间46779例转为透析的晚期DKD患者(腹膜透析4216例,血液透析42563例)。我们计算了从透析前5年到透析后10年的严重低血糖发生率。采用Cox比例风险模型研究晚期DKD患者转为透析后终末期肾病(ESRD)一年低血糖和ESRD一年死亡率的危险因素。

结果

我们发现,11.5%的晚期DKD患者在开始透析前一年至少有一次严重低血糖发作。多变量分析显示,与腹膜透析相比,血液透析、中风、使用磺脲类药物、格列奈类药物和胰岛素与转为透析一年后严重低血糖的风险较高有关。转为透析一年后,严重低血糖相关住院频率增加与死亡风险逐步升高相关(ESRD前低血糖:风险比:1.28(1.18⁻1.38,<0.001),1.64(1.49⁻1.81,<0.001)分别对应一次、两次低血糖相关住院;ESRD后低血糖:一次、两次低血糖相关住院的风险比分别为1.56(1.40⁻1.73,<0.001),1.72(1.39⁻2.12,<0.001)(参照组:无低血糖相关住院))。

结论

在晚期DKD患者中,我们观察到在关键的透析过渡期低血糖风险逐渐升高。转为透析一年后,严重低血糖相关住院频率增加与死亡风险较高有关。有必要进一步研究在关键过渡期预防低血糖的血糖管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee62/6518047/0c853cf78a34/jcm-08-00420-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee62/6518047/a4f29d5efa1e/jcm-08-00420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee62/6518047/0ed836c1dae9/jcm-08-00420-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee62/6518047/0c853cf78a34/jcm-08-00420-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee62/6518047/a4f29d5efa1e/jcm-08-00420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee62/6518047/0ed836c1dae9/jcm-08-00420-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee62/6518047/0c853cf78a34/jcm-08-00420-g003.jpg

相似文献

1
Temporal Trends of Severe Hypoglycemia and Subsequent Mortality in Patients with Advanced Diabetic Kidney Diseases Transitioning to Dialysis.晚期糖尿病肾病患者转为透析后严重低血糖及随后死亡率的时间趋势
J Clin Med. 2019 Mar 27;8(4):420. doi: 10.3390/jcm8040420.
2
Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study.晚期糖尿病肾病透析患者低血糖的流行病学及结局:一项全国队列研究
PLoS One. 2017 Mar 29;12(3):e0174601. doi: 10.1371/journal.pone.0174601. eCollection 2017.
3
Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis.糖尿病患者透析过渡期与低血糖相关的住院和死亡。
Am J Kidney Dis. 2018 Nov;72(5):701-710. doi: 10.1053/j.ajkd.2018.04.022. Epub 2018 Jul 20.
4
Ketoanalogue supplements reduce mortality in patients with pre-dialysis advanced diabetic kidney disease: A nationwide population-based study.酮类似物补充剂可降低透析前晚期糖尿病肾病患者的死亡率:一项基于全国人口的研究。
Clin Nutr. 2021 Jun;40(6):4149-4160. doi: 10.1016/j.clnu.2021.01.045. Epub 2021 Feb 6.
5
Diabetes-related end-stage renal disease in Austria 1965-2013.1965 - 2013年奥地利的糖尿病相关终末期肾病
Nephrol Dial Transplant. 2015 Nov;30(11):1920-7. doi: 10.1093/ndt/gfv113. Epub 2015 May 13.
6
Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.在进入透析的晚期慢性肾脏病患者中,终末期肾病前血清碱性磷酸酶对终末期肾病后死亡率的预后意义。
Nephrol Dial Transplant. 2018 Feb 1;33(2):264-273. doi: 10.1093/ndt/gfw412.
7
Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis.终末期肾病前血红蛋白变异性预测透析转换患者终末期肾病后死亡率。
Am J Nephrol. 2017;46(5):397-407. doi: 10.1159/000484356. Epub 2017 Nov 7.
8
Sixteen prescribed Chinese herbal medicines provide time-dependent cardiorenal and survival benefits in patients with overall and advanced diabetic kidney disease: a real-world study in Taiwan.16种常用中药对总体和晚期糖尿病肾病患者具有时间依赖性的心肾保护和生存益处:台湾的一项真实世界研究
Front Pharmacol. 2024 Aug 22;15:1297854. doi: 10.3389/fphar.2024.1297854. eCollection 2024.
9
Association of Pre-End-Stage Renal Disease Serum Albumin With Post-End-Stage Renal Disease Outcomes Among Patients Transitioning to Dialysis.终末期肾病前血清白蛋白与透析患者过渡后终末期肾病结局的关系。
J Ren Nutr. 2019 Jul;29(4):310-321. doi: 10.1053/j.jrn.2018.09.004. Epub 2019 Jan 11.
10
Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes.终末期肾病前血红蛋白与早期透析结局的关联。
Am J Nephrol. 2018;47(5):333-342. doi: 10.1159/000489223. Epub 2018 May 18.

引用本文的文献

1
Incidence and influencing factors for hypoglycemia in maintenance hemodialysis patients with diabetic kidney disease: a meta-analysis.糖尿病肾病维持性血液透析患者低血糖的发生率及影响因素:一项荟萃分析
Am J Transl Res. 2024 Oct 15;16(10):5216-5227. doi: 10.62347/ESHE6987. eCollection 2024.
2
Risk factors for short-term all-cause mortality in patients with end stage renal disease: a scoping review.终末期肾病患者短期全因死亡率的风险因素:范围综述。
BMC Nephrol. 2024 Feb 27;25(1):71. doi: 10.1186/s12882-024-03503-3.
3
Burden of impaired awareness of hypoglycemia in people with diabetes undergoing hemodialysis.

本文引用的文献

1
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States.《美国肾脏数据系统2016年年报:美国肾脏疾病流行病学》
Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2016.12.004.
2
Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: Findings from the FADOI-DIAMOND study.在内科病房住院的2型糖尿病患者低血糖的危险因素:FADOI-DIAMOND研究结果
Diabetes Res Clin Pract. 2016 May;115:24-30. doi: 10.1016/j.diabres.2016.01.020. Epub 2016 Mar 7.
3
Evaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease.
血液透析患者中未察觉低血糖症的负担。
BMJ Open Diabetes Res Care. 2024 Feb 1;12(1):e003730. doi: 10.1136/bmjdrc-2023-003730.
4
Multimorbidity, Polypharmacy, Severe Hypoglycemia, and Glycemic Control in Patients Using Glucose-Lowering Drugs for Type 2 Diabetes: A Retrospective Cohort Study Using Health Insurance Claims in Japan.使用降糖药物治疗2型糖尿病患者的多重疾病、多重用药、严重低血糖和血糖控制:一项利用日本医疗保险理赔数据的回顾性队列研究
Diabetes Ther. 2023 Jul;14(7):1175-1192. doi: 10.1007/s13300-023-01421-5. Epub 2023 May 17.
5
Narrative Review of Glycemic Management in People With Diabetes on Peritoneal Dialysis.腹膜透析糖尿病患者血糖管理的叙述性综述
Kidney Int Rep. 2023 Feb 9;8(4):700-714. doi: 10.1016/j.ekir.2023.01.040. eCollection 2023 Apr.
6
Insulin use in chronic kidney disease and the risk of hypoglycemic events.慢性肾脏病患者使用胰岛素与低血糖事件风险。
BMC Nephrol. 2022 Feb 21;23(1):73. doi: 10.1186/s12882-022-02687-w.
7
Biomarkers of Glyco-Metabolic Control in Hemodialysis Patients: Glycated Hemoglobin vs. Glycated Albumin.血液透析患者糖代谢控制的生物标志物:糖化血红蛋白与糖化白蛋白。
Medicina (Kaunas). 2021 Jul 14;57(7):712. doi: 10.3390/medicina57070712.
8
Incidence and risk factors associated with hypoglycemia among patients with chronic kidney disease: A systematic review.慢性肾病患者低血糖的发生率及相关危险因素:一项系统评价
J Family Community Med. 2020 Sep-Dec;27(3):157-162. doi: 10.4103/jfcm.JFCM_304_19. Epub 2020 Sep 25.
9
Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.血液透析的 2 型糖尿病患者的糖化白蛋白和即时连续血糖监测系统估算的血红蛋白 A1c 水平评估的血糖控制水平的显著差异。
J Diabetes Investig. 2020 Nov;11(6):1570-1574. doi: 10.1111/jdi.13286. Epub 2020 Jun 9.
10
Promises of Big Data and Artificial Intelligence in Nephrology and Transplantation.大数据与人工智能在肾脏病学和移植领域的前景
J Clin Med. 2020 Apr 13;9(4):1107. doi: 10.3390/jcm9041107.
终末期肾病中糖尿病和非糖尿病低血糖的评估和管理。
Nephrol Dial Transplant. 2016 Jan;31(1):8-15. doi: 10.1093/ndt/gfv258. Epub 2015 Jul 6.
4
Haemodialysis-induced hypoglycaemia and glycaemic disarrays.血液透析引起的低血糖和血糖紊乱。
Nat Rev Nephrol. 2015 May;11(5):302-13. doi: 10.1038/nrneph.2015.38. Epub 2015 Apr 7.
5
Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan.台湾地区患者自我报告与医保理赔数据在临床诊断、用药情况及卫生系统利用方面的一致性。
PLoS One. 2014 Dec 2;9(12):e112257. doi: 10.1371/journal.pone.0112257. eCollection 2014.
6
Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes.慢性肾脏病和强化血糖控制增加 2 型糖尿病患者的心血管风险。
Kidney Int. 2015 Mar;87(3):649-59. doi: 10.1038/ki.2014.296. Epub 2014 Sep 17.
7
Severe hypoglycemia identifies vulnerable patients with type 2 diabetes at risk for premature death and all-site cancer: the Hong Kong diabetes registry.严重低血糖可识别 2 型糖尿病患者发生过早死亡和全癌风险的脆弱人群:香港糖尿病登记处。
Diabetes Care. 2014 Apr;37(4):1024-31. doi: 10.2337/dc13-2507. Epub 2014 Feb 10.
8
Increased mortality early after dialysis initiation: a universal phenomenon.透析启动后早期死亡率升高:一种普遍现象。
Kidney Int. 2014 Jan;85(1):12-4. doi: 10.1038/ki.2013.316.
9
Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database.在国民健康保险理赔数据库中验证急性缺血性中风的诊断
J Formos Med Assoc. 2015 Mar;114(3):254-9. doi: 10.1016/j.jfma.2013.09.009. Epub 2013 Oct 18.
10
Worldwide, mortality risk is high soon after initiation of hemodialysis.在全球范围内,开始血液透析后不久死亡风险就很高。
Kidney Int. 2014 Jan;85(1):158-65. doi: 10.1038/ki.2013.252. Epub 2013 Jun 26.